People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Other, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Forma Therapeutics Holdings LLC | — | Other | Series C | $60.1M | $171.5M | 2011 |
| StanChem Holdings, LLC | — | Manufacturing | Series B | $15.3M | $167.7M | 2017 |
Michael A. Foley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael A. Foley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Finn | 1 | 5 |
| Thong-Yuen Poon | 1 | 3 |
| Alexis A. Borisy | 1 | 3 |
| Steven Tregay, Ph.D. | 1 | 2 |
| Steven Hall | 1 | 2 |
| John W. Waller | 1 | 1 |
| Peter A. Hunter | 1 | 1 |
| Reinhard Ambros, Ph.D. | 1 | 1 |
| Andrew Littlehale | 1 | 1 |
| James A. Ward | 1 | 1 |
| Paul A. Stenson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.